A24.3
Other melioidosis
Clinical Classification Guidelines
Medical Intelligence & Overview
Other melioidosis, classified under ICD-10 code A24.3, refers to a form of the infectious disease melioidosis that does not fall under the more common or specific classifications. Melioidosis is caused by the bacterium *Burkholderia pseudomallei*, which is native to Southeast Asia and northern Australia. This condition can affect multiple organ systems and presents with various symptoms, making accurate diagnosis and management vital. Although considered rare or atypical within the spectrum of melioidosis cases, 'other melioidosis' signifies cases that require particular clinical attention due to their unique presentation or spread.
Causes & Symptoms
Clinical Causes: Infection by *Burkholderia pseudomallei*, typically via skin contact with contaminated soil or water Inhalation of dust or aerosols containing the bacteria Ingestion of contaminated water or food Environmental exposure in endemic regions, especially during rainy seasons
Key Symptoms: Fever and chills Localized pain or swelling in affected areas Abscess formation in organs such as the liver, spleen, or lungs Cough, shortness of breath, or chest discomfort when lungs are involved Headache or neurological symptoms if the bacteria affect the nervous system Muscle and joint pains Fatigue and malaise Potential skin ulcers or rashes
Diagnostic & Treatment
Diagnosis Path: Diagnosis often involves a combination of clinical evaluation and laboratory testing. Healthcare providers may perform:
Treatment Protocols: Treatment approaches generally include the use of specific antibiotics and supportive care. Common treatment strategies involve:
Clinical Advice & FAQs
Billing Guidance
Is A24.3 a billable ICD-10 code?
Yes, A24.3 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report A24.3?
Clinical documentation must specify the nature of Other melioidosis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
